Depression relief was the primary driver of disease improvement among patients with fibromyalgia and prominent anxiety and depression symptoms.

In patients with newly diagnosed fibromyalgia who have prominent symptoms of anxiety and depression, remission of depression — not pain reduction alone — determines clinical improvement.

Globally, nearly 51% of patients with fibromyalgia had depression, and 47% experienced anxiety in a new meta-analysis. Additionally, there were trends for anxiety prevalence decreasing with age and ...

In addition, post-hoc analyses showed improvement in depression, anxiety, memory and energy items on the Fibromyalgia Impact Questionnaire-Revised New Drug Application (NDA) submission to the FDA on ...

Between four and 10 million people in the U.S. have fibromyalgia. Many doctors look askance at the disorder, leading some patients to seek pain relief from substance use.

Among patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA), intense pain symptoms were associated with poor sleep, fibromyalgia, depression, and sleep apnea. “In general, studies ...

There’s a lot to focus on when it comes to treating fibromyalgia. Learn whether you could benefit from having more mental health support, better medication options, help identifying triggers, or ...

TORONTO, Aug. 31, 2023 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in ...

Research found a self-guided smartphone-based behavioral therapy led to significant improvements for patients with fibromyalgia. New research led by the University of Cincinnati and Swing Therapeutics ...